Aller au contenu principal
Accès ouvert déclaré 2026 article

Assessment of greenhouse gas emission of type 2 diabetes management in adults: a modelling study in the UK

1Citations signalées, ce qui n’est pas une note de qualité
12Institutions déclarées
9Pays d’affiliation déclarés

Rattachement africain : dk, kr, fr, jp, gb, in, es, ch, it. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background The carbon footprint of end-to-end healthcare deliveries by the National Health Service in England totalled 25.0 megatons of carbon dioxide equivalent (CO 2 e) in 2019. Optimal and sustainable healthcare can lead to better health outcomes as well as a lower environmental footprint. Objectives To evaluate the potential impact of prevention and effective management of type 2 diabetes mellitus (T2DM) in adults on both the clinical outcomes and greenhouse gas (GHG) emissions in the UK healthcare setting. Research design and methods We incorporated an environmental module into the existing IQVIA core diabetes model to estimate the impact of improving clinical outcomes on GHG emissions over a lifetime horizon. We assessed two hypothetical scenarios: (1) preventing progression from pre-diabetes to T2DM through diet and exercise versus no intervention and natural disease progression to T2DM; and (2) well-controlled T2DM using interventions with clinical benefit on glycosylated haemoglobin (HbA1c), and renal and cardiovascular outcomes versus uncontrolled T2DM. Results Preventing progression to T2DM led to 6.357 additional undiscounted life years and 67% less kg CO 2 e emissions compared with subsequent natural progression to T2DM for a person with pre-diabetes over a lifetime (emissions of 9586 kg CO 2 e over 37.115 years vs 28 716 kg CO 2 e over 30.758 years, respectively). Well-controlled T2DM led to 1.947 additional undiscounted life years and 21% less kg CO 2 e emissions per patient over a lifetime compared with uncontrolled T2DM (emissions of 14 545 kg CO 2 e over 22.772 years vs 18 516 kg CO 2 e over 20.825 years, respectively). In both scenarios, the GHG emission savings were primarily due to reduced emissions related to avoidance of treating complications of T2DM including cardiovascular, renal and eye diseases. Conclusion Effective prevention and management of T2DM through implementation of evidence-based clinical guidelines can improve patient outcomes while reducing the healthcare-related environmental impacts.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Assessment of greenhouse gas emission of type 2 diabetes management in adults: a modelling study in the UK
Date Crossref
01/01/2026
Éditeur
BMJ
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Climate Change and Health ImpactsAgriculture Sustainability and Environmental ImpactHealth, Environment, Cognitive Aging

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.